Ever Source Wealth Advisors, LLC 89bio, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in 89bio, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 294 shares of ETNB stock, worth $4,351. This represents 0.0% of its overall portfolio holdings.
Number of Shares
294
Previous 181
62.43%
Holding current value
$4,351
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ETNB
# of Institutions
214Shares Held
161MCall Options Held
299KPut Options Held
1.61M-
Janus Henderson Group PLC London, X020.8MShares$308 Million0.11% of portfolio
-
Ra Capital Management, L.P. Boston, MA19.9MShares$294 Million4.27% of portfolio
-
Suvretta Capital Management, LLC New York, NY14.2MShares$210 Million4.8% of portfolio
-
Deep Track Capital, LP Greenwich, CT9.5MShares$141 Million3.31% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.24MShares$122 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $688M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...